As with any other poison, viruses are usually deadlier in larger amounts.
By Joshua D. Rabinowitz and Caroline R. Bartman
Dr. Rabinowitz is a professor of chemistry and genomics. Dr. Bartman is a genomic researcher.
Li
Wenliang, the doctor in China who raised early awareness of the new
coronavirus, died of the virus in February at 34. His death was shocking
not only because of his role in publicizing the developing epidemic but
also — given that young people do not have a high risk of dying from
Covid-19 — because of his age.
Is it
possible that Dr. Li died because as a doctor who spent a lot of time
around severely ill Covid-19 patients, he was infected with such a high
dose? After all, though he was one of the first young health care
workers to die after being exposed up close and frequently to the virus,
he was unfortunately not the last.
The
importance of viral dose is being overlooked in discussions of the
coronavirus. As with any other poison, viruses are usually more
dangerous in larger amounts. Small initial exposures tend to lead to
mild or asymptomatic infections, while larger doses can be lethal.
From
a policy perspective, we need to consider that not all exposures to the
coronavirus may be the same. Stepping into an office building that once
had someone with the coronavirus in it is not as dangerous as sitting
next to that infected person for an hourlong train commute.
This may seem obvious, but many people are not making this distinction. We need to focus more on preventing high-dose infection.
Both
small and large amounts of virus can replicate within our cells and
cause severe disease in vulnerable individuals such as the
immunocompromised. In healthy people, however, immune systems respond as
soon as they sense a virus growing inside. Recovery depends on which
wins the race: viral spread or immune activation.
Virus
experts know that viral dose affects illness severity. In the lab, mice
receiving a low dose of virus clear it and recover, while the same
virus at a higher dose kills them. Dose sensitivity has been observed
for every common acute viral infection that has been studied in lab
animals, including coronaviruses.
Humans
also exhibit sensitivity to viral dose. Volunteers have allowed
themselves to be exposed to low or high doses of relatively benign
viruses causing colds or diarrhea. Those receiving the low doses have
rarely developed visible signs of infection, while high doses have
typically led to infections and more severe symptoms.
It
would be unethical to experimentally manipulate viral dose in humans
for a pathogen as serious as the coronavirus, but there is evidence that
dose also matters for the human coronavirus. During the 2003 SARS
coronavirus outbreak in Hong Kong, for instance, one patient infected
many others living in the same complex of apartment buildings, resulting
in 19 dead. The spread of infection is thought to have been caused by
airborne viral particles that were blown throughout the complex from the
initial patient’s apartment unit. As a result of greater viral
exposure, neighbors who lived in the same building were not only more
frequently infected but also more likely to die. By contrast, more
distant neighbors, even when infected, suffered less.
Despite the evidence for the
importance of viral dose, many of the epidemiological models being used
to inform policy during this pandemic ignore it. This is a mistake.
People
should take particular care against high-dose exposures, which are most
likely to occur in close in-person interactions — such as coffee
meetings, crowded bars and quiet time in a room with Grandma — and from
touching our faces after getting substantial amounts of virus on our
hands. In-person interactions are more dangerous in enclosed spaces and
at short distances, with dose escalating with exposure time. For
transient interactions that violate the rule of maintaining six feet
between you and others, such as paying a cashier at the grocery store,
keep them brief — aim for “within six feet, only six seconds.”
Because
dose matters, medical personnel face an extreme risk, since they deal
with the sickest, highest-viral-load patients. We must prioritize
protective gear for them.
For everyone
else, the importance of social distancing, mask-wearing and good
hygiene is only greater, since these practices not only decrease
infectious spread but also tend to decrease dose and thus the lethalness
of infections that do occur. While preventing viral spread is a
societal good, avoiding high-dose infections is a personal imperative,
even for young healthy people.
At the
same time, we need to avoid a panicked overreaction to low-dose
exposures. Clothing and food packaging that have been exposed to someone
with the virus seem to present a low risk. Healthy people who are
together in the grocery store or workplace experience a tolerable risk —
so long as they take precautions like wearing surgical masks and
spacing themselves out.
A complete
lockdown of society is the most effective way to stop spread of the
virus, but it is costly both economically and psychologically. When
society eventually reopens, risk-reduction measures like maintaining
personal space and practicing proper hand-washing will be essential to
reducing high-dose infections. High-risk sites for high-dose exposure,
like stadiums and convention venues, should remain shuttered. Risky but
essential services like public transportation should be allowed to
operate — but people must follow safety measures such as wearing masks,
maintaining physical spacing and never commuting with a fever.
Now
is the time to stay home. But hopefully this time will be brief. When
we do begin to leave our homes again, let’s do it wisely, in light of
the importance of viral dose.
Joshua D. Rabinowitz is a professor of chemistry and genomics at Princeton, where Caroline R. Bartman is a research fellow.